One Mind™ Accelerator Announces Fourth Cohort of Startups, Advancing Mental Health Innovation

Audio By Carbonatix

MENLO PARK, Calif.--(BUSINESS WIRE)--Feb 9, 2026--

One Mind™, a leading mental health nonprofit based in Napa Valley, CA, today announced the selected startups of the 2026 One Mind Accelerator, a 10-week immersive program designed to offer critical domain expertise and hands-on support for business development, company building, fundraising, and founder development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209994908/en/

2026 One Mind Accelerator Launch Announcement

This is the fourth cohort of the One Mind Accelerator since its launch in 2023. The 14 companies in the 2026 cohort were selected from a record-breaking number of applicants, reflecting a less than 5% acceptance rate and bringing the total number of companies in the One Mind Accelerator portfolio to 51. The first 37 companies have raised nearly $1 billion since their Demo Day, and have impacted 1 million people with lived experience so far.

The 2026 cohort companies span pre-seed, seed, and Series A stages, and were chosen for their potential to transform the diagnosis, treatment, management, and prevention of mental illness. Together, they are addressing the mental health crisis across the full spectrum of severity and lifespan - from subclinical mental health challenges to serious mental illness, and from pediatric to geriatric care. These startups are leveraging the recent technological inflections in clinical AI, spatial computing, biomarkers, and non-invasive brain imaging and stimulation, alongside growing policy and societal emphasis on chronic disease and lifestyle-based interventions.

The 14 companies chosen for the 2026 One Mind Accelerator cohort are:

• Biomia: Biomia is a biotech company developing a pipeline of novel, nature-inspired, human-validated small-molecule therapeutics to treat CNS disorders, including schizophrenia.
• Birches Health: Birches Health is a digital behavioral health company that provides insurance-covered, specialized care for gambling, sex and pornography, video gaming, and internet and social media addiction.
• Eratos Therapeutics: Eratos enables high-specificity therapeutic target identification through predictive, AI-driven nanoscale world maps of the brain, accelerating precision-engineered CNS drug discovery.
• Flow Neuroscience: Flow Neuroscience is pioneering a new category of at-home electric medicine, delivering drug-free, brain-based mental health treatments—the world’s first clinically validated, FDA-approved at-home transcranial direct current stimulation headset.
• Forecast Bio: Forecast Bio is building an AI-powered preclinical platform that directly links complex cellular neurobiology to patients’ mental health outcomes. By mapping how new drugs impact human brain circuits and symptoms, Forecast is speeding up therapeutic development by 10x.
• Limbic: Limbic is a clinically-validated AI agent for mental healthcare, used by health systems and payers across the UK and US. The AI has supported more than 600,000 patients in treatment, and is the only AI mental health chatbot approved as a Class II medical device.
• Manatee: Manatee is a family mental health provider addressing the pediatric mental health crisis by treating the entire family system, including parents. Manatee’s evidence-based, whole-family model is proven to be 4x more engaging and 3x more effective than traditional, child-only therapy.
• Monument Therapeutics: Monument Therapeutics is a neuroscience-focused drug development company using digital biomarkers to develop more targeted treatments for neurological and psychiatric disorders, including schizophrenia.
• Neurofundus: Neurofundus is building foundation models for precision psychiatry by comprehensively mapping phenotypic and biological disease subtypes to enable personalized treatment trajectories and precision drug discovery.
• Nosis Health: Nosis Health is a digital health company building a new model for substance use care that integrates addiction medicine, advanced diagnostics, therapy, coaching, and lifestyle interventions, to build health and vitality, not just stopping use.
• Orbit Neuro: Orbit is building foundation models of cognitive states and conditions, enabling precision mental healthcare. Orbit is collecting unprecedentedly rich neural datasets, enabled by their novel brain wearable which can achieve fMRI-comparable resolution at scale.
• Radicle Science: Radicle Science fuses AI, consumer science, and massive real-world clinical trials to scalably develop and validate effective, precise, nonprescription mental health treatments that are accessible to all.
• SocialRX: SocialRx is a healthcare-grade social prescribing platform that helps health plans, employers, and universities tackle the growing crisis of loneliness and mental health in the United States through arts, culture, and nature.
• Vitalic Health: Vitalic Health is a geriatric-specialized and team-based behavioral health practice that uniquely provides the proactive outreach and engagement required to enroll and treat often reluctant 65+ members into behavioral healthcare.

"This year's cohort represents the forefront of mental health science, innovation, and treatment. As technology, including AI, redefines what's possible, these founders are ready to meet the moment and meaningfully improve the care that is available to individuals and families seeking new and highly effective solutions," said Kathleen M. Pike, PHD, CEO of One Mind.

The 2026 session begins with a week of in-person programming from February 9th-13th in Menlo Park, CA, followed by eight weeks of virtual programming, and culminating in an in-person Demo Day on April 15th, also in Menlo Park. One Mind’s extensive network of entrepreneurs, investors, mental health advocates, operators, payers, providers, and scientists serve as mentors and subject matter experts for the cohort.

“Since its launch, the One Mind Accelerator has focused on addressing the mental health crisis by helping early-stage companies bring their innovations to market faster and with greater impact,” said Carmine Di Maro, Executive Director of the One Mind Accelerator. “This year’s programming is tailored to the specific growth stages and needs of each founding team, allowing us to better support relationship-building, business development, and fundraising. With the support of our generous donors and best-in-class industry partners, we provide an unparalleled level of access and expertise. Over the past three years, the Accelerator has facilitated more than 1,000 introductions and hosted over 300 expert sessions, leading to closed contracts, top-tier advisory boards, and C-level talent recruitment.”

Highlights from the 2026 opening week of programming include a Keynote by Russell Glass, the former CEO of Headspace; a State and Local Government Panel with senior representatives from the California Commission for Behavioral Health, Los Angeles County Department of Mental Health, Texas Health and Human Services, and Department of Health and Mental Hygiene - New York City; a Federal Government Panel with senior representatives from the Advanced Research Projects Agency for Health, National Institute of Mental Health, Substance Abuse and Mental Health Services Administration, and the Council of Economic Advisers to The White House; an Investor Panel with representatives from ARCH Venture Partners, GreyMatter Capital, Khosla Ventures, Satori Neuro, and Skyline Capital; a Payer Panel with Cigna Healthcare, CVS Health, HCSC, Navigator Healthcare, Optum, and the Yale University School of Medicine; and a Provider Panel with Intermountain Healthcare, Kaiser Permanente, Mass General Brigham McLean, Sutter Health and UC Davis.

As a 501(c)(3) nonprofit, One Mind is grateful to receive generous philanthropic support from private donors, foundations, and corporate sponsors who together make the One Mind Accelerator possible. These include Bank of America, Baszucki Group, Penner Family Foundation and Resonance Philanthropies as lead supporters, as well as support from Anthony Pritzker Family Foundation, The Dr. Daniel C. Cooper Brain Health Research Fund, Flourish Impact Fund, Greenbridge Family Foundation, Rainwater Foundation, Unlikely Collaborators, and the Wellcome Trust. One Mind also receives substantial support from an anonymous donor, as well as the Board of Directors and others who provide unrestricted contributions. ​​

"One Mind Accelerator has been a great partner and feeder of innovative teams with the potential to dramatically change how patients are supported or treated, especially in youth mental health — an area we have supported actively over the last three decades,” said Sheri Sobrato, Founder of Resonance Philanthropies, and a philanthropic supporter of the One Mind Accelerator since its inception.

For additional information and questions about the One Mind Accelerator, including about the closing week from April 13th - April 15th, please contact Carmine Di Maro, Executive Director, One Mind Accelerator: [email protected]

​​About One Mind™

One Mind is a Napa Valley, CA-based nonprofit dedicated to improving mental health outcomes for individuals, families, and society. With science as our foundation and people at the heart of our mission, One Mind supports early-career scientists with bold ideas, empowers passionate entrepreneurs developing real-world solutions, and leads a global coalition of business leaders committed to improving mental health in the workplace.

Founded in 1995 by business leaders and philanthropists Garen and Shari Staglin following their son Brandon’s diagnosis with schizophrenia, One Mind was created to bridge critical gaps in mental health research funding and patient support. Guided by this enduring purpose, One Mind strives to transform knowledge into actionable solutions that foster mental health and healing for individuals whose lives are impacted by mental illness.

About the One Mind Accelerator

​​The One Mind Accelerator (OMA) is a Silicon Valley-based nonprofit accelerator for early-stage startups developing breakthrough solutions for mental health. Launched in 2023 by One Mind, the program selects a cohort of 10-16 startups each year and backs them with network, education, and capital through an intensive 10-week hybrid program. OMA is funded via philanthropic contributions to One Mind, which receives advisory shares from participating companies, with all proceeds reinvested back into the nonprofit.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260209994908/en/

One Mind,[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH HEALTH MENTAL HEALTH

SOURCE: One Mind

Copyright Business Wire 2026.

PUB: 02/09/2026 09:00 AM/DISC: 02/09/2026 09:04 AM

http://www.businesswire.com/news/home/20260209994908/en